
Immunogenicity of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in subpopulations of healthy adults 18-70 years of age
Keywords: سن; Hepatitis B vaccine; Toll-like receptor 9; Age; Sex; BMI; Smokers; NCT00435812; NCT01005407;